Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…on. 100% of patients were taking Lithium LP 400mg, indicated in bipolar disorder. The mean consultation lasted 42.5 minutes. 100% of patients we…
…frequent for erenumab (31%), followed by galcanezumab (27%) and eptinezumab (15%).Conclusion and Relevance Treatment effectiveness was obse…
…rometry (Q Exactive Plus instrumentation) were used to quantify metformin concentrations. Values below 100 ng/ml were deemed subtherapeut…
… 20% and 30% of patients, respectively, and 90% achieved higher ustekinumab levels post-intervention.Conclusion and Relevance Although ADA …
…human immunodeficiency virus infection and those diagnosed with heterozygous familial hypercholesterolaemia. In patients with cardiovascular risk factors diagnosed with di…
…was uncommon in both groups (10% in trials vs 1% in real life). Tocilizumab was administered in all trial cases (20/20) versus 66% (200/303…
… prescriptions (PIPs) that exceed the maximum recommended dose: omeprazole, esomeprazole and rabeprazole ≥ 40 mg/day, pantoprazole ≥ 80 mg…
…or intramuscularly (26/60, 43%). The most common diagnoses were rheumatoid arthritis (37/60, 61.7%) and psoriatic arthritis (11/60, 18.3%).Conclusio…
…allenges when pregnancy is planned. Anti-CD20 therapies such as ofatumumab are effective; however, their safety during pregnancy remains u…
…mplications.Conclusion and Relevance In this real-world cohort, axi-cel showed predictable but significant toxicity, including universa…
…d into EP are effective in improving patient safety by reducing MEs and ADEs, especially those related to antimicrobials and in eld…
…HP, and no one in this group had minimal HP. The results in the dexamethasone group were less favourable. The least favourable outcomes were …